50242-0917 Tecentriq - CanMED: NDC

Product NDC:

50242-0917

Brand Name:

Tecentriq

Generic Name:

Atezolizumab

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: Atezolizumab

Strength: 1200.0

Unit: mg/20mL

Packages:

Code: 50242-0917-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1 VIAL, SINGLE-USE

Effective Date: May 18, 2016

Discontinued:

Code: 50242-0917-86

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1 VIAL, SINGLE-USE

Effective Date: Aug. 11, 2016

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-L1

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox